• DNDi logo
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Global Headquarters
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia/India
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
DNDi logo
  • DNDi logo
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Global Headquarters
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia/India
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

DNDi’s 3rd Partners’ Meeting in collaboration with Indian Council of Medical Research (ICMR)

3 December 2010

New Delhi, India

Share on twitter
Share on facebook
Share on linkedin
Share on email
Share on print
 

Like in 2009 in Nairobi, Drugs for Neglected Diseases initiative (DNDi) brought together more than 150 Indian and international health researchers, policy makers, experts from 22 countries on December 3rd, at the Constitutional Club in New Delhi for the 3rd International Partners meeting organized by DNDi in collaboration with Indian Council for Medical Research (ICMR), to stimulate greater regional research partnership to fight the most neglected diseases such as Kala-azar sleeping sickness, malaria and Chagas disease.

Hon’ble Union Minister Shri Ghulam Nabi Azad, Ministry of Health & Family Welfare was invited to open this international meeting in presence of Dr. V.M. Katoch, Secretary to Government of India, Department of Health research and Director General of ICMR.

During this meeting, two projects were highlighted as DNDi’s successes of the Year 2010 respectively. These projects showed important breakthroughs in research and development for neglected diseases and global collaboration between scientists from over the world.


Agenda

If you would like to download the Agenda, please click here.


Programme

If you would like to download the Programme, please click here.


Presentations

Session 1: Opening Ceremony and Presentation of DNDi Strategy

Chaired by Marcel Tanner / Bhawna Sharma
1. Inauguration and Opening Ceremony
2. Welcoming Remarks
3. Needs of Neglected Patients – Focus on India & Asia – by Bhawna Sharma (DNDi) [download 974KB]
4. Review of DNDi Activities – by Bernard Pécoul (DNDi) [download 2.3MB]
5. Announcement of DNDi‘s “Success Stories” of the Year (Partnership / Project of the Year)

Session 2: Success to Pave the Way for the Future of PDPs Model 

Chaired by Monique Wasunna / Lalit Kant
1. From Patient Needs to Implementation of New Treatments
– VL Combination Therapies – by Shyam Sundar
(Institute of Medical Sciences, Banaras Hindu University, India) [download 2.8MB]
– Fixed-Dose ACTs for Malaria – by Neena Valecha
(National Institute of Malaria Research, India) [download 2.1MB]
2. Discovery and Lead Optimisation Programs: A future generation of drugs for neglected diseases –
and  – by Rashmi Barbhaiya (Advinus) and Yves Ribeill (SCYNEXIS) [ download part 1, 1.MB, part 2, 672KB]

Session 3: Advocacy for Access & Sustainability of the Model

Chaired by Bennett Shapiro / Carlos Morel
1
. Sustainability of PDP’s Model- by Nirmal K Ganguly (Transnational Health Science and Technology Institute, India) [download 693KB]
2. Advocacy for Access – by Unni Karunakara (MSF)[download 312KB]

Session 4

Chaired by Marcel Tanner / Vishwa Mohan Katoch
1. Next priorities in terms of diseases – Evolution of DNDi portfolio – by Shing Chang (DNDi) [download 1MB]
2. Movie preview “1 $ fpr 1 life” documentary
3. Concluding remarks

 

Press Release

If you would like to download the Press Release, please click here.


Videos

Partnership of the Year

The “Partnership of the Year” award went to the Institute Pasteur Korea (IPK) programme for an important technological breakthrough on drug discovery in the field of Visceral Leishmaniasis (VL) also known as Kala-azar, and other neglected diseases. The main goal of the partnership has been to develop a method that would allow the testing of thousands of compounds in a very short period of time. Until 2008, it was only possible to assess hundreds of compounds in a few months. DNDi and IPK have developed a new method called “high throughput image screening” for Kala-azer. Utilising both the intellectual and technological capacities of IPK, this project seeks to develop a major methodological advance in drug development.

Project of the Year

The “Project of the year” award went to the Visceral Leishmaniasis Combination Therapies project in India. This clinical research study, completed in 2010, showed that three combination therapies of existing drugs for Visceral Leishmaniasis (VL), also known as Kala-azar, are highly efficacious and  offer shorter, safer and cheaper treatment options than the current standard monotherapy treatment available in the region.

1$ for 1 Life

A documentary by the filmmaker Frédéric Laffont

Press Articles

To read the article “Together they can…” of  Express Pharma, click here.

Photos

  • Dr. Shing Chang, R&D Director, DNDi, presenting during Session 4 (Next priorities in terms of diseases: Evolution of DNDi portfolio)
  • Team of the “Partnership of the Year” – The award went to the Institute Pasteur Korea programme for an important technological breakthrough on drug discovery in the field of Kala-azar and other neglected diseases
  • Announcement of DNDi’s “Success Stories” of the Year - Shiv Dayal Seth, Member of DNDi Scientific Advisory Committee
  • Team of the “Partnership of the Year” – The award went to the Institute Pasteur Korea programme for an important technological breakthrough on drug discovery in the field of Kala-azar and other neglected diseases
  • Speakers of Session 2 (Success to pave the way for the future PDPs model)
  • Dr. Neena Valecha, Deputy Director, National Institute of Malaria Research, India, presenting during Session 2
  • Dr. Rashmi Barbhaiya, CEO, Advinus, presenting during Session 2
  • Dr. Rob Don, Discovery & Preclinical Director and Head of HAT Discovery & Preclinical Program, DNDi, presenting in Session 2
  • Dr. Monique Wasunna, Head of DNDi Africa, chairing Session 2
  • Speakers of Session 2 (Success to pave the way for the future PDPs model)
  • Dr. Shyam Sundar, Professor of Medicine, Institute of Medical Sciences, Banaras Hindu University, India, presenting during Session 2
  • Speakers of Session 2 (Success to pave the way for the future PDPs model)
  • Paul Lalvani
  • Dr. Bennett Shapiro, Chair of DNDi Board of Directors North America, chairing Session 3 (Advocacy for access & sustainability of the model)
  • Dr. Farrokh Modabber, Senior Advisor for Leishmaniasis, DNDi, co-chairing Session 3 (Advocacy for access & sustainability of the model)
  • Dr. Nirmal K. Ganguly, Distinguished Biotechnology Fellow and Advisor, Translational Health Science and Technology Institute, India, panelist during Session 3
  • Dr. Mel Spigelman, President & CEO, Global Alliance for TB Drug Development, panelist during Session 3
  • Welcoming remarks – Marcel Tanner, Director of the Swiss Tropical and Public Health Institute, Chair of DNDi Board
  • Audience
  • Stage of the DNDi’s 3rd Partners’ Meeting in collaboration with ICMR
  • Welcoming remarks - Dr.V.M. Katoch, Secretary, Department of Health Research, Government of India & Director-General, ICMR.
  • Welcoming remarks – Dr. Bernard Pécoul, DNDi Executive Director
  • Welcoming remarks – Marcel Tanner, Director of the Swiss Tropical and Public Health Institute, Chair of DNDi Board
  • Opening ceremony – Lightening ceremony - Dr.V.M. Katoch, Dr. Bernard Pécoul, Dr. Marcel Tanner
  • Opening ceremony – Lightening ceremony - Dr.V.M. Katoch, Dr. Bernard Pécoul, Dr. Marcel Tanner, Dr. Bhawna Sharma
  • Dr. Piero Olliaro, WHO/Special Programme for Research and Training in Tropical Diseases (TDR), panelist during Session 3
  • Dr. Unni Karunakara, President, International Medecins Sans Frontières, panelist during Session 3
  • The representative of the Swiss Embassy in New Dehli
  • Dr. Ahmed Musa, IED, Sudan & Chair LEAP Platform, panelist in Session 3
  • Dr. Abul Faiz, Sir Salimullah Medical College, Bangladesh, panelist in Session 3
  • Dr. Jaideep Gogtay, MD, Medical Director, CIPLA, panelist in Session 3
  • Dr. Tarun Bhatnagar, MD, Resident Director - Corporate Affairs, sanofi-aventis India, panelist in Session 3

Other events

Loading...
1-6 August 2022

Cartagena, Colombia

WorldLeish 7

12-15 July 2022

Munich, Germany

22nd Drug Design & Development Seminar

29-30 June 2022

Online

ISNTD d3 2022

28 June - 1 July 2022

Singapore

Global Health Security Conference 2022

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

DNDi logo
Facebook-f
Twitter
Instagram
Linkedin-in
Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License   
We use cookies to track our audience and improve our content. By clicking 'Accept All', you are agreeing to our use of cookies. Click on 'Customize' to accept only some cookies.
Customize
ACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-advertisement1 yearSet by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent1 yearRecords the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
elementorneverThis cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time.
PHPSESSIDsessionThis cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThe _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_16Q5RH3XRG2 yearsThis cookie is installed by Google Analytics.
_gat_UA-10302561-11 minuteA variation of the _gat cookie set by Google Analytics and Google Tag Manager to allow website owners to track visitor behaviour and measure site performance. The pattern element in the name contains the unique identity number of the account or website it relates to.
_gid1 dayInstalled by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
_hjAbsoluteSessionInProgress30 minutesHotjar sets this cookie to detect the first pageview session of a user. This is a True/False flag set by the cookie.
_hjFirstSeen30 minutesHotjar sets this cookie to identify a new user’s first session. It stores a true/false value, indicating whether it was the first time Hotjar saw this user.
_hjIncludedInPageviewSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's pageview limit.
_hjIncludedInSessionSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's daily session limit.
_hjSession_112884430 minutesNo description
CONSENT2 yearsYouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.
Targeting
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
CookieDurationDescription
_hjSessionUser_11288441 yearNo description
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
SAVE & ACCEPT
Powered by CookieYes Logo